
"The UltraSEEK EGFR Panel has the capacity to detect the most common EGFR activating mutations and the emerging Osimertinib resistance EGFR C797S mutation in a single-well reaction."
-Dr. Weiwei Zhao
Director, Clinical Genomic Testing Center, KingMed Diagnostics (Webinar, 9 Aug 2018)